17 Feb 2021

South Africa scraps AstraZeneca, pivots to Johnson & Johnson vaccine

South Africa is giving up its stock of Oxford-AstaZeneca Covid-19 vaccines to the African Union and instead is seeking to vaccinate its population with the single-dose Johnson & Johnson drug. The changes in the Covid-19 vaccination policy come after the AstraZeneca vaccine proved to offer minimal protection against the variant

Read More
14 Oct 2020

Johnson & Johnson Halt All Covid-19 Vaccine Trials Over ‘Unexplained Illness’

Johnson & Johnson, a US-based pharmaceutical company, has put its COVID-19 vaccine trials on hold due to safety concerns following an unexplained illness in a participant. AstraZeneca made a similar move in September for identical reasons. The company released a statement on Monday, claiming that it was unclear what caused

Read More